Replies to post #29299 on OncoSec Medical Inc (ONCSQ)

[ahab333]

Tom, after listening to the webinar & reading what you said, you seem to be spot on! I agree and I too will stay for the future GLTU

HCIT

[dr_lowenstein]

Gee if there really was a collaboration or partnership with Merck, one would expect the CEO to say that

[mybikeisorange]

Nice post Tom. I haven't listened to the webinar, but sounds about like how I expected it would go.

Good to hear from someone that else understands the true extent of the Merck relationship. Thanks for confirmation on the P2b patient sample size. Again I haven't listened to the call, but my understanding was that the interim data possibly to presented in 4Q was for the P2a expanded study, not the P2b combo study. Can you confirm that?

I agree that everything depends on those P2b results. ONCS is putting the pieces together now in preparation for those results to be positive. If positive, good things will happen. We still have a long way to go though.

[tootalljones]

agreed. eom.

[lasers]

TomP1 Thxs for the summary

As well from the $ONCS website both Melanoma trials

(1) Metastatic Melanoma

(2) Melanoma Combination study EP– IL12 + Anti-PD1 (KEYTRUDA®)


are proceeding as Phase2B Slide 20 of 32




An excellent summary of $ONCS latest important info as of Mar, 2015

http://content.stockpr.com/oncosec/media/3edbc526ab7184e1257fcbcac727954e.pdf